+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 21Years - 50Years
All Genders
ID07515456

Comparing Theophylline, Sumatriptan, and Gabapentin for Treating Post-Dural Puncture Headache in Adults Aged 21 to 50

Led by Tanta University · Updated on 2026-04-07

75

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare the safety and effectiveness of three drugs theophylline, sumatriptan, and gabapentin in treating post-dural puncture headache PDPH, a common complication following spinal anesthesia or dural puncture. PDPH causes discomfort for patients and challenges for anesthetists. The study explores these medications because of their different mechanisms theophylline may reduce blood flow and venous enlargement in the brain, sumatriptan may prevent cerebral blood vessel dilation related to cerebrospinal fluid leaks, and gabapentin is used for nerve-related pain conditions. Participants will be randomly assigned to one of three groups. One group will receive oral theophylline tablets of 150 mg every 12 hours. Another group will take oral sumatriptan tablets of 25 mg every 12 hours. The third group will receive 200 mg of gabapentin every 12 hours. Treatment is provided as tablets taken by mouth, and the study is designed to be double-blinded so neither participants nor researchers know which treatment is given. During the study, researchers will monitor headache severity 24 hours after treatment begins, along with headache duration, length of hospital stay up to two weeks, any side effects related to treatment, use of additional pain relief, and patient satisfaction. The overall participation involves regular assessments during hospital stay, focusing on the immediate outcomes following drug administration. The trial starts in December 2024 and continues until November 2026, involving adults aged 21 to 50 years.

CONDITIONS

Brief Title

Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture Headache

Research Team

A

Asmaa R Eid, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here